But Paul Herrling, head of corporate research at Novartis, says such investments could go far, as the firm does not expect to do the costly bitsof drug development, such as clinical trials, itself.
Perhaps all the talk of customer development, lean startups, crowdsourcing, and the myriad bitsof startup lingo has obscured the simplest truth: Starting is about problem-identifying and problem-solving.